Moderna Inc (MRNA): Next-Year EPS Estimate 45.07%
As of 2026-06-04, Moderna Inc (MRNA) has a next-year EPS growth estimate of 45.07%.
On 2026-05-24, analyst consensus for MRNA's next-year EPS growth shifted from 45.39% to 45.07% — a negative change of 0.32 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at -18.38%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 45.07%
- EPS growth this year
- -18.38%
- EPS next quarter (est)
- -$2.06
- Last price
- $51.59
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 45.07% | -18.38% | -$2.06 | $51.59 |
| 2026-06-03 | 45.07% | -18.38% | -$2.06 | $49.06 |
| 2026-06-02 | 45.07% | -18.38% | -$2.06 | $45.64 |
| 2026-06-01 | 45.07% | -18.38% | -$2.06 | $46.06 |
| 2026-05-31 | 45.07% | -18.38% | -$2.06 | $47.19 |
| 2026-05-28 | 45.07% | -18.38% | -$2.06 | $47.57 |
| 2026-05-27 | 45.07% | -18.38% | -$2.06 | $47.61 |
| 2026-05-26 | 45.07% | -18.38% | -$2.06 | $47.03 |
| 2026-05-25 | 45.07% | -18.38% | -$2.06 | $46.88 |
| 2026-05-24 | 45.07% | -18.38% | -$2.06 | $46.88 |
| 2026-05-21 | 45.39% | -19.29% | -$2.06 | $47.26 |
| 2026-05-20 | 44.97% | -18.38% | -$2.06 | $48.12 |
| 2026-05-19 | 44.38% | -17.20% | -$2.06 | $45.72 |
| 2026-05-18 | 44.38% | -17.20% | -$2.06 | $48.11 |
| 2026-05-17 | 44.38% | -17.20% | -$2.06 | $49.04 |
| 2026-05-14 | 44.38% | -17.20% | -$2.06 | $50.03 |
| 2026-05-13 | 44.38% | -17.20% | -$2.06 | $50.42 |
| 2026-05-12 | 44.38% | -17.20% | -$2.06 | $53.27 |
| 2026-05-11 | 44.38% | -17.20% | -$2.06 | $52.88 |
| 2026-05-10 | 44.38% | -17.20% | -$2.06 | $54.35 |
| 2026-05-07 | 44.38% | -17.20% | -$2.06 | $48.54 |
| 2026-05-06 | 44.38% | -17.20% | -$2.06 | $48.79 |
| 2026-05-05 | 42.97% | -14.49% | -$2.06 | $46.71 |
| 2026-05-04 | 42.23% | -13.20% | -$2.07 | $47.30 |
| 2026-05-03 | 41.89% | -12.61% | -$2.11 | $45.37 |
| 2026-04-30 | 40.27% | -9.98% | -$4.45 | $45.94 |
| 2026-04-29 | 40.27% | -9.98% | -$4.45 | $45.72 |
| 2026-04-28 | 40.26% | -9.98% | -$4.44 | $47.14 |
| 2026-04-27 | 40.26% | -9.98% | -$4.45 | $48.70 |
| 2026-04-26 | 36.46% | -1.47% | -$2.01 | $50.73 |
Recent News
- Kailera makes history with record-breaking $625m IPOPharmaceutical Technology
- OpenAI is launching a specialized AI model for drug discovery and life sciences researchQuartz
- Kailera nets $625M in one of biotechs biggest-ever IPOsBioPharma Dive
- Bank of America flags international opportunities as key growth driver for ModernaProactive
- Moderna eyes international markets as growth driver, says Bank of AmericaProactive
- Bank of America flags international opportunities as key growth driver for ModernaProactive
- Moderna eyes international markets as growth driver, says Bank of AmericaProactive
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Moderna Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Moderna Inc (MRNA) has a next-year EPS growth estimate of 45.07%, based on analyst consensus.
When was the latest EPS estimate revision for MRNA?▾
The most recent revision occurred on 2026-05-24, when analysts adjusted the next-year EPS growth estimate from 45.39% to 45.07%.
What sector and industry does Moderna Inc belong to?▾
Moderna Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. MRNA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Moderna Inc (MRNA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports